Neuropeptides and dementia.

[1]  C. Marsden,et al.  Dementia and Parkinson's disease--pathological and neurochemical considerations. , 1986, British medical bulletin.

[2]  B. Winblad,et al.  Transmitter deficits in Alzheimer's disease , 1985, Neurochemistry International.

[3]  D. F. Swaab,et al.  The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia , 1985, Brain Research.

[4]  E. Fliers,et al.  The vasopressin and oxytocin neurons in the human supraoptic and paraventricular nucleus; changes with aging and in senile dementia , 1985, Brain Research.

[5]  M. Beal,et al.  Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease. , 1985, Science.

[6]  R. Terry,et al.  Somatostatin-like immunoreactivity within neuritic plaques , 1985, Brain Research.

[7]  D. Neary,et al.  Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. , 1985, The New England journal of medicine.

[8]  T. Crow,et al.  Dissociation of neuropeptide Y and somatostatin in Parkinson's disease , 1985, Brain Research.

[9]  D. Mash,et al.  Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. , 1985, Science.

[10]  J. Richard,et al.  Evidence for the existence of serotonin type-2 receptors on cholinergic terminals in rat cortex , 1985, Brain Research.

[11]  T. Crow,et al.  Location of neuronal tangles in somatostatin neurones in Alzheimer's disease , 1985, Nature.

[12]  F. Bloom,et al.  Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients , 1985, Nature.

[13]  P. Francis,et al.  Relevance of reduced concentrations of somatostatin in Alzheimer's disease , 1985 .

[14]  D. Dawbarn,et al.  Neuropeptide Y-like immunoreactivity in neuritic plaques of Alzheimer's disease. , 1985, Biochemical and biophysical research communications.

[15]  P. Sørensen,et al.  Cerebrospinal fluid vasopressin in neurological and psychiatric disorders. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[16]  D. Price,et al.  Evidence for cholinergic neurites in senile plaques. , 1984, Science.

[17]  E. Sinforiani,et al.  Central ACTH deficit in degenerative and vascular dementia. , 1984, Life sciences.

[18]  E G Jones,et al.  Neuropeptide-containing neurons of the cerebral cortex are also GABAergic. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Neary,et al.  Somatostatin-like immunoreactivity in lumbar cerebrospinal fluid from neurohistologically examined demented patients , 1984, Neurobiology of Aging.

[20]  J. Corwin,et al.  CSF somatostatin in Alzheimer's disease , 1984, Neurobiology of Aging.

[21]  K. Kosaka,et al.  Changes of Biogenic Amines and Their Metabolites in Postmortem Brains from Patients with Alzheimer‐Type Dementia , 1984, Journal of neurochemistry.

[22]  T. Kemper,et al.  Nucleus Raphe Dorsalis in Dementia of the Alzheimer Type: Neurofibrillary Changes and Neuronal Packing Density , 1984, Journal of neuropathology and experimental neurology.

[23]  D. Fitzpatrick,et al.  GABAergic neurons of mammalian cerebral cortex: Widespread subclass defined by somatostatin content , 1984, Neuroscience Letters.

[24]  I. Ferrier,et al.  Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia , 1984, Journal of the Neurological Sciences.

[25]  L. Iversen,et al.  Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia. , 1984, Brain : a journal of neurology.

[26]  F. Eckenstein,et al.  Two types of cholinergic innervation in cortex, one co-localized with vasoactive intestinal polypeptide , 1984, Nature.

[27]  I. Nakano,et al.  Parhnson’s Disease: Neuron Loss in the Nucleus Basah Without Concomitant Alzheimer’s Disease , 2004 .

[28]  T. Crow,et al.  Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type , 1984, Journal of the Neurological Sciences.

[29]  C. Bouras,et al.  Mapping of enkephalins in human brain An immunohistofluorescence study on brains from patients with senile and presenile dementia , 1984, Neuroscience.

[30]  D. Neary,et al.  Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[31]  L. Iversen,et al.  Neurochemical characteristics of early and late onset types of Alzheimer's disease. , 1984, British medical journal.

[32]  T. Halonen,et al.  Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type , 1984, Journal of the Neurological Sciences.

[33]  L. Iversen,et al.  Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type , 1984, Neuroscience Letters.

[34]  M. Dichter,et al.  Coexistence of acetylcholinesterase and somatostatin-immunoreactivity in neurons cultured from rat cerebrum. , 1984, Science.

[35]  T. Powell,et al.  Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase , 1983, Brain Research.

[36]  H. Fibiger,et al.  Substance P in the ascending cholinergic reticular system , 1983, Nature.

[37]  Yves Agid,et al.  A subcortico-cortical cholinergic system is affected in Parkinson's disease , 1983, Brain Research.

[38]  T. Crow,et al.  Neuropeptide Y distribution in human brain , 1983, Nature.

[39]  A. Paetau,et al.  A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease , 1983, Journal of the Neurological Sciences.

[40]  I. Ferrier,et al.  Neuropeptides in Alzheimer type dementia , 1983, Journal of the Neurological Sciences.

[41]  J. Simpson,et al.  Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and down's syndrome , 1983, Brain Research.

[42]  Y. Agid,et al.  Somatostatin and dementia in Parkinson's disease , 1983, Brain Research.

[43]  P. Sørensen,et al.  CSFandplasma vasopressmconcentrations in dementia , 1983 .

[44]  S. M. Sumi,et al.  Alzheimer's disease: Choline acetyltransferase activity in brain tissue from clinical and pathological subgroups , 1983, Annals of neurology.

[45]  E. Perry,et al.  Monoamine metabolism in senile dementia of Alzheimer type , 1983, Journal of the Neurological Sciences.

[46]  J. Ulrich,et al.  Neuritic plaques in senile dementia of Alzheimer type: a Golgi analysis in the hippocampal region , 1983, Brain Research.

[47]  Joseph B. Martin,et al.  Somatostatin is increased in the basal ganglia in Huntington disease , 1983, Annals of neurology.

[48]  T. Hökfelt,et al.  Occurrence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in the human medulla oblongata , 1983, Neuroscience Letters.

[49]  P. Mcgeer,et al.  Choline acetyltransferase immunohistochemistry in brains of alzheimer's disease patients and controls , 1983, Neuroscience Letters.

[50]  D. Rubinow,et al.  CSF somatostatin in affective illness. , 1983, Archives of general psychiatry.

[51]  D. Neary,et al.  Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease , 1983, Brain Research.

[52]  D L Price,et al.  Alzheimer's disease: a disorder of cortical cholinergic innervation. , 1983, Science.

[53]  F. Bloom,et al.  Immunohistochemical distribution of pro-somatostatin-related peptides in cerebral cortex , 1983, Brain Research.

[54]  D L Price,et al.  Basal forebrain neurons in the dementia of Parkinson disease , 1983, Annals of neurology.

[55]  E. Perry,et al.  Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression , 1983, Journal of the Neurological Sciences.

[56]  G. Fink,et al.  Thyrotropin-releasing hormone, luteinizing hormone-releasing hormone and substance P immuno-reactivity in post-mortem brain from cases of alzheimer-type dementia and Down's syndrome , 1983, Brain Research.

[57]  D. Neary,et al.  Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease , 1983, Journal of neurochemistry.

[58]  M. Forsling,et al.  Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases. , 1983, Journal of neurology, neurosurgery, and psychiatry.

[59]  E. Perry,et al.  Some Observations and Speculations Concerning the Cholinergic System and Neuropeptides in Alzheimer's Disease , 1983 .

[60]  R. Katzman.,et al.  Biological aspects of Alzheimer's disease , 1983 .

[61]  R. Perry,et al.  The cholinergic system in Alzheimer's disease , 1982, Trends in Neurosciences.

[62]  S. Hunt,et al.  Extrahypothalamic vasopressin is unchanged in Parkinson's disease and Huntington's disease , 1982, Brain Research.

[63]  T. Crow,et al.  CORTICAL MUSCARINIC RECEPTOR SUBTYPES AND ALZHEIMER'S DISEASE , 1982, The Lancet.

[64]  M. Esiri,et al.  Alzheimer's disease Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities , 1982, Journal of the Neurological Sciences.

[65]  M. Rossor.  Neurotransmitters and CNS disease. Dementia. , 1982, Lancet.

[66]  S. Cajal,et al.  Reduced lumbar CSF somatostatin levels in Alzheimer's disease. , 1982, Life sciences.

[67]  N. Brecha,et al.  The morphology and distribution of peptide-containing neurons in the adult and developing visual cortex of the rat. III. Cholecystokinin , 1982, Journal of neurocytology.

[68]  J. Coyle,et al.  Somatostatin is not co-localized in cholinergic neurons innervating the rat cerebral cortex-hippocampal formation , 1982, Brain Research.

[69]  T. Hökfelt,et al.  Neuropeptide coexistence in human cortical neurones , 1982, Nature.

[70]  P. Davies,et al.  Cortical Substance P‐Like Immunoreactivity in Cases of Alzheimer's Disease and Senile Dementia of the Alzheimer Type , 1982, Journal of neurochemistry.

[71]  M N Rossor,et al.  A post-mortem study of the cholinergic and GABA systems in senile dementia. , 1982, Brain : a journal of neurology.

[72]  K. V. Sørensen.  Somatostatin: Localization and distribution in the cortex and the subcortical white matter of human brain , 1982, Neuroscience.

[73]  D. Price,et al.  Cholinergic innervation in neuritic plaques. , 1982, Science.

[74]  J. Coyle,et al.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.

[75]  A. P. Hansen,et al.  Low cerebrospinal fluid somatostatin in Parkinson disease , 1982, Neurology.

[76]  S. Hunt,et al.  The substantia innominata in alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes , 1982, Neuroscience Letters.

[77]  W. Bondareff,et al.  Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia , 1982, Neurology.

[78]  Y. Agid,et al.  Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia , 1982, Brain Research.

[79]  E. Perry,et al.  Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes , 1981, Neurobiology of Aging.

[80]  L. Iversen,et al.  Neurotransmitters of the cerebral cortex in senile dementia of Alzheimer type. , 1982, Experimental brain research.

[81]  L. Iversen,et al.  CHOLINERGIC DEFICIT IN FRONTAL CEREBRAL CORTEX IN ALZHEIMER'S DISEASE IS AGE DEPENDENT , 1981, The Lancet.

[82]  F. Goodwin,et al.  Cholecystokinin receptors are decreased in basal ganglia and cerebral cortex of Huntington's disease , 1981, Brain Research.

[83]  E. Perry,et al.  Neuropeptides in Alzheimer's disease, depression and schizophrenia A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex , 1981, Journal of the Neurological Sciences.

[84]  H. Olpe,et al.  Vasopressin activates noradrenergic neurons in the rat locus coeruleus: A microiontophoretic investigation , 1981 .

[85]  Joseph B. Martin,et al.  The regional distribution of somatostatin, substance P and neurotensin in human brain , 1981, Brain Research.

[86]  J. Rehfeld,et al.  Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer type. , 1981, Life sciences.

[87]  P. Millard,et al.  Investigation of cerebrospinal fluid neuropeptides in idiopathic senile dementia. , 1981, Gerontology.

[88]  S. Vincent,et al.  A substance P projection to the hippocampus , 1981, Brain Research.

[89]  L. Iversen,et al.  Extrahypothalamic vasopressin in human brain , 1981, Brain Research.

[90]  M. Rossor,et al.  The regional distribution and chromatographic behaviour of somatostatin in human brain , 1981, Neuroscience Letters.

[91]  P. Davies,et al.  Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile Dementia of the Alzheimer type , 1981, Neurobiology of Aging.

[92]  M. Leon,et al.  Central amine metabolism in Alzheimer's disease: In vivo relationship to cognitive deficit , 1981, Neurobiology of Aging.

[93]  G. Blessed,et al.  Cell loss in the locus coeruleus in senile dementia of Alzheimer type , 1981, Journal of the Neurological Sciences.

[94]  F. Goodwin,et al.  Effects of vasopressin on human memory functions. , 1981, Science.

[95]  Jau-Shyong Hong,et al.  Intrahippocampal distribution of Met5-enkephalin , 1981, Brain Research.

[96]  S. Hunt,et al.  Presence of avian pancreatic polypeptide-like immunoreactivity in catecholamine and methionine-enkephalin-containing neurones within the central nervous system , 1981, Neuroscience Letters.

[97]  T. Crow,et al.  Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease , 1981, British medical journal.

[98]  L. Iversen,et al.  ARGININE VASOPRESSIN AND CHOLINE ACETYLTRANSFERASE IN BRAINS OF PATIENTS WITH ALZHEIMER TYPE SENILE DEMENTIA , 1980, The Lancet.

[99]  L. Iversen,et al.  Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects , 1980, Journal of the Neurological Sciences.

[100]  L. Iversen,et al.  Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type , 1980, Neuroscience Letters.

[101]  R. Katzman.,et al.  Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa , 1980, Nature.

[102]  P. Emson,et al.  Reduced corticol choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide , 1980, Brain Research.

[103]  J. Simpson,et al.  Neurochemical observations in a case of Pick's disease , 1980, Journal of the Neurological Sciences.

[104]  J. Rehfeld,et al.  Reduction in cholecystokinin-like immunoreactivity in the basal ganglia in Huntington's disease , 1980, Brain Research.

[105]  T. Kemper,et al.  Amygdaloid changes in aging and dementia. , 1980, Archives of neurology.

[106]  E. Critchley,et al.  Peripheral neuropathy due to perhexilene maleate , 1980, Journal of the Neurological Sciences.

[107]  E. Spokes,et al.  Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue. , 1980, Brain : a journal of neurology.

[108]  A. P. Hansen,et al.  Low somatostatin content in cerebrospinal fluid in multiple sclerosis , 1980, Acta neurologica Scandinavica.

[109]  D. Neary,et al.  GLUCOSE METABOLISM AND ACETYLCHOLINE SYNTHESIS IN RELATION TO NEURONAL ACTIVITY IN ALZHEIMER'S DISEASE , 1980, The Lancet.

[110]  E. Perry,et al.  Histochemical observations on cholinesterase activities in the brains of elderly normal and demented (Alzheimer-type) patients. , 1980, Age and ageing.

[111]  G. Kovacs,et al.  The effects of vasopressin on memory processes: The role of noradrenergic neurotransmission , 1979, Neuroscience.

[112]  P. Emson,et al.  Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's disease , 1979, Brain Research.

[113]  B. Winblad,et al.  Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer Type , 1979, British Journal of Psychiatry.

[114]  P. Davies.  Neurotransmitter-related enzymes in senile dementia of the alzheimer type , 1979, Brain Research.

[115]  W. Meier-Ruge,et al.  ACCELERATED AGEING OR SELECTIVE NEURONAL LOSS AS AN IMPORTANT CAUSE OF DEMENTIA? , 1979, The Lancet.

[116]  E K Perry,et al.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. , 1978, British medical journal.

[117]  P. Cuatrecasas,et al.  Immunohistochemical localization of enkephalin in rat brain and spinal cord , 1978, The Journal of comparative neurology.

[118]  L. Forno.  THE LOCUS CAERULEUS IN ALZHETMERʼS DISEASE , 1978 .

[119]  P. Emson,et al.  The substance P projections to the frontal cortex and the substantia nigra , 1978, Neuroscience Letters.

[120]  Peter Davies,et al.  Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains , 1977, Brain Research.

[121]  Robert H. Perry,et al.  Neurotransmitter enzyme abnormalities in senile dementia Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue , 1977, Journal of the Neurological Sciences.

[122]  J. Spillane,et al.  Selective vulnerability of neurones in organic dementia , 1977, Nature.

[123]  J. Edwards,et al.  HUNTINGTON'S CHOREA , 1977, The Lancet.

[124]  G. Blessed,et al.  NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA , 1977, The Lancet.

[125]  P. Davies,et al.  SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.

[126]  D M Bowen,et al.  Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. , 1976, Brain : a journal of neurology.

[127]  B. Roos,et al.  HOMOVANILLIC ACID AND 5‐HYDROXYINDOLEACETIC ACID IN THE CEREBROSPINAL FLUID OF PATIENTS WITH SENILE DEMENTIA, PRESENILE DEMENTIA AND PARKINSONISM , 1969, Journal of neurochemistry.

[128]  H. Cookson,et al.  A Case of Primary Amyloid Heart , 1962, British medical journal.

[129]  M. Roth,et al.  Psychological test performance in patients over sixty. I. Senile psychosis and the affective disorders of old age. , 1953, The Journal of mental science.